Tjoapack has had a strong presence at key industry events this year, and DCAT Week 2025 was no exception.
‍
As part of a roundtable hosted by 24/7 Biopharma, our Senior Director of Global Business Development, Joe Compton, joined a panel of experts to explore how CDMOs and their suppliers are evolving their collaboration models to meet growing demands for speed, complexity, and personalization.

In the feature, Joe highlights how Tjoapack is responding through strategic investments in cold chain capacity, injectable packaging formats, and automation—helping clients deliver sensitive, personalized therapies efficiently and at scale. His insights reflect a broader industry shift toward more integrated, innovation-driven partnerships.

📖 Read the full article to see how CDMOs like Tjoapack are helping shape a more agile and collaborative pharma future.

‍

‍